Amount Raised
$72.5 Million
Round Type
Post-IPO Equity
MorristownBiotechnologyHealth CareTherapeuticsDescription
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced it has entered into a securities purchase agreement with a new accredited investor and certain existing investors to issue and sell an aggregate of 3,373,526 shares of its common stock ("Common Stock") at a price of $12.50 per share, reflecting the closing price on September 21, 2022 on NASDAQ, and pre-funded warrants ("Pre-Funded Warrants") to purchase up to an aggregate of 2,426,493 shares of Common Stock at a purchase price of $12.4999 per pre-funded warrant share, through a private investment in public equity ("PIPE") financing. The Pre-Funded Warrants will have an exercise price of $0.0001 per share of Common Stock, to be immediately exercisable and remain exercisable until exercised in full. Aadi Bioscience anticipates the gross proceeds from the PIPE to be approximately $72.5 million, before deducting any offering related expenses
Quick answer
Whitehawk Therapeutics, Inc. raised $72.5 Million in a Post-IPO Equity round, dated September 22, 2022. Whitehawk Therapeutics, Inc. is based in Morristown, New Jersey, United States.
- How much did Whitehawk Therapeutics, Inc. raise?
- Whitehawk Therapeutics, Inc. raised $72.5 Million in a Post-IPO Equity round on September 22, 2022.
- Where is Whitehawk Therapeutics, Inc. based and how big is it?
- Whitehawk Therapeutics, Inc. is based in Morristown, New Jersey, United States.
- Who are the decision-makers at Whitehawk Therapeutics, Inc?
- Fundz holds 3 contacts at Whitehawk Therapeutics, Inc., including the President & Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Whitehawk Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Novadip Biosciences raised $39M (Funding Round) on November 4, 2022.
- Zenas BioPharma raised $184M on November 2, 2022.
- Biofrontera raised $3.7M (Seed) on October 25, 2022.
- MapLight Therapeutics raised $12M on October 25, 2022.
- Insmed Incorporated raised an undisclosed amount (Funding Round) on October 19, 2022.
- Orionis Biosciences raised $55M (Funding Round) on October 19, 2022.
Who to call at Whitehawk Therapeutics, Inc., and when
A new round usually means Whitehawk Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Whitehawk Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Whitehawk Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Whitehawk Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Whitehawk Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Whitehawk Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.